Roche
A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated
September 20, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma
Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
NICE rejects Roche’s Ocrevus in primary progressive multiple sclerosis
September 10, 2018Sales and Marketing NICE, Ocrevus, Roche, UK, multiple sclerosis, pharma
Of the 100,000 MS patients in England, around one in eight have the primary progressive form (PPMS), which brings debilitating …
Rheos Medicines appoints Roche Senior Vice President and R&D head as new CEO
September 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, CEO, Roche, cembridge, massachussets, rheos, sanjay keswani
The Cambridge Massachusetts-based biopharmaceutical company Rheos Medicines has appointed former Roche Senior Vice President and Global R&D Head, Dr Sanjay …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
Chinese regulators approve Roche’s Alecensa in regulatory shift
August 20, 2018Sales and Marketing Cancer, China, Roche, approval, lung cancer
China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …
Genentech to axe 223 staff from San Francisco HQ
August 17, 2018Manufacturing and Production, Medical Communications Genentech, Roche, layoffs, pharma
Roche subsidiary Genentech has announced plans to axe 223 employees from its headquarters in San Francisco, California, beginning on 31 …
Lawsuit alleges pharma giants funded terror in Iraq
August 2, 2018Business Services, Medical Communications, Sales and Marketing AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism
The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
Roche join Pfizer and others in price freeze while critics pose questions
July 23, 2018Sales and Marketing Donald Trump, Roche, generics, price freezes
Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …
Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?
July 17, 2018Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma
Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …
Roche’s Tecentriq combo gives strong Phase 3 showing in triple negative breast cancer
July 2, 2018Research and Development, Sales and Marketing Cancer, Roche, breast cancer, pharma
Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …
Top Ten most popular articles on Pharmafile.com this week
June 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Remicade, Roche, biosimilar Amgen, lung cancer, multiple sclerosis, pharma
Summer seems to be in full swing as we reach the end of June, so it’s time to look back …
NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis
June 29, 2018Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma
Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …
Roche’s Tecentriq combo extends life in untreated lung cancer
June 25, 2018Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq
Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …
Roche buys out rest of Foundation Medicine for $2.4bn
June 19, 2018Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical
Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
